BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25691421)

  • 1. Partial MEF2C deletion in a Cypriot patient with severe intellectual disability and a jugular fossa malformation: review of the literature.
    Tanteles GA; Alexandrou A; Evangelidou P; Gavatha M; Anastasiadou V; Sismani C
    Am J Med Genet A; 2015 Mar; 167A(3):664-9. PubMed ID: 25691421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdeletion 5q14.3 and anomalies of brain development.
    Hotz A; Hellenbroich Y; Sperner J; Linder-Lucht M; Tacke U; Walter C; Caliebe A; Nagel I; Saunders DE; Wolff G; Martin P; Morris-Rosendahl DJ
    Am J Med Genet A; 2013 Sep; 161A(9):2124-33. PubMed ID: 23824879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEF2C deletions and mutations versus duplications: a clinical comparison.
    Novara F; Rizzo A; Bedini G; Girgenti V; Esposito S; Pantaleoni C; Ciccone R; Sciacca FL; Achille V; Della Mina E; Gana S; Zuffardi O; Estienne M
    Eur J Med Genet; 2013 May; 56(5):260-5. PubMed ID: 23402836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C.
    Nowakowska BA; Obersztyn E; Szymańska K; Bekiesińska-Figatowska M; Xia Z; Ricks CB; Bocian E; Stockton DW; Szczałuba K; Nawara M; Patel A; Scott DA; Cheung SW; Bohan TP; Stankiewicz P
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):1042-51. PubMed ID: 20333642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine phenotypes in a boy with 5q14 deletion syndrome implicate the regulatory roles of myocyte-specific enhancer factor 2C in the postnatal hypothalamus.
    Sakai Y; Ohkubo K; Matsushita Y; Akamine S; Ishizaki Y; Torisu H; Ihara K; Sanefuji M; Kim MS; Lee KU; Shaw CA; Lim J; Nakabeppu Y; Hara T
    Eur J Med Genet; 2013 Sep; 56(9):475-83. PubMed ID: 23832106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial 1q23.3q24.1 deletion in a patient with renal malformation, congenital heart disease, and mild intellectual disability.
    Mackenroth L; Hackmann K; Klink B; Weber JS; Mayer B; Schröck E; Tzschach A
    Am J Med Genet A; 2016 Sep; 170(9):2394-9. PubMed ID: 27255444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEF2C haploinsufficiency syndrome: Report of a new MEF2C mutation and review.
    Rocha H; Sampaio M; Rocha R; Fernandes S; Leão M
    Eur J Med Genet; 2016 Sep; 59(9):478-82. PubMed ID: 27255693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal detection of 5q14.3 duplication including MEF2C and brain phenotype.
    Cesaretti C; Spaccini L; Righini A; Parazzini C; Conte G; Crosti F; Redaelli S; Bulfamante G; Avagliano L; Rustico M
    Am J Med Genet A; 2016 May; 170A(5):1352-7. PubMed ID: 26864752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive investigation of the phenotype of MEF2C-related disorders in human patients: A systematic review.
    Cooley Coleman JA; Sarasua SM; Boccuto L; Moore HW; Skinner SA; DeLuca JM
    Am J Med Genet A; 2021 Dec; 185(12):3884-3894. PubMed ID: 34184825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial deletion of ANKRD11 results in the KBG phenotype distinct from the 16q24.3 microdeletion syndrome.
    Khalifa M; Stein J; Grau L; Nelson V; Meck J; Aradhya S; Duby J
    Am J Med Genet A; 2013 Apr; 161A(4):835-40. PubMed ID: 23494856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleft Lip Palate in a Patient with 5q14.3 Deletion Syndrome: A Possible Unreported Feature?
    Fernández Hernández L; Alcántara Ortigoza MA; Ramos Angeles SE; González-Del Angel A
    Cytogenet Genome Res; 2021; 161(12):556-563. PubMed ID: 35021179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular findings in 39 patients with KBG syndrome caused by deletion or mutation of ANKRD11.
    Goldenberg A; Riccardi F; Tessier A; Pfundt R; Busa T; Cacciagli P; Capri Y; Coutton C; Delahaye-Duriez A; Frebourg T; Gatinois V; Guerrot AM; Genevieve D; Lecoquierre F; Jacquette A; Khau Van Kien P; Leheup B; Marlin S; Verloes A; Michaud V; Nadeau G; Mignot C; Parent P; Rossi M; Toutain A; Schaefer E; Thauvin-Robinet C; Van Maldergem L; Thevenon J; Satre V; Perrin L; Vincent-Delorme C; Sorlin A; Missirian C; Villard L; Mancini J; Saugier-Veber P; Philip N
    Am J Med Genet A; 2016 Nov; 170(11):2847-2859. PubMed ID: 27605097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype-genotype correlation of a patient with a "balanced" translocation 9;15 and cryptic 9q34 duplication and 15q21q25 deletion.
    Papadopoulou E; Sismani C; Christodoulou C; Ioannides M; Kalmanti M; Patsalis P
    Am J Med Genet A; 2010 Jun; 152A(6):1515-22. PubMed ID: 20503328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum.
    Shimojima K; Okumura A; Mori H; Abe S; Ikeno M; Shimizu T; Yamamoto T
    Am J Med Genet A; 2012 Sep; 158A(9):2272-6. PubMed ID: 22848023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report.
    Yauy K; Schneider A; Ng BL; Gaillard JB; Sati S; Coubes C; Wells C; Tournaire M; Guignard T; Bouret P; Geneviève D; Puechberty J; Pellestor F; Gatinois V
    BMC Med Genomics; 2019 Aug; 12(1):116. PubMed ID: 31375103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic characterization and genotype/phenotype analysis in a patient with a de novo 8p23.2p23.3 deletion/12p13.31p13.33 duplication.
    Margari L; Di Cosola ML; Buttiglione M; Pansini A; Buonadonna AL; Craig F; Cariola F; Petruzzelli MG; Gentile M
    Am J Med Genet A; 2012 Jul; 158A(7):1713-8. PubMed ID: 22639464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo microdeletions of chromosome 6q14.1-q14.3 and 6q12.1-q14.1 in two patients with intellectual disability - further delineation of the 6q14 microdeletion syndrome and review of the literature.
    Becker K; Di Donato N; Holder-Espinasse M; Andrieux J; Cuisset JM; Vallée L; Plessis G; Jean N; Delobel B; Thuresson AC; Annerén G; Ravn K; Tümer Z; Tinschert S; Schrock E; Jønch AE; Hackmann K
    Eur J Med Genet; 2012; 55(8-9):490-7. PubMed ID: 22561202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
    Le Meur N; Holder-Espinasse M; Jaillard S; Goldenberg A; Joriot S; Amati-Bonneau P; Guichet A; Barth M; Charollais A; Journel H; Auvin S; Boucher C; Kerckaert JP; David V; Manouvrier-Hanu S; Saugier-Veber P; Frébourg T; Dubourg C; Andrieux J; Bonneau D
    J Med Genet; 2010 Jan; 47(1):22-9. PubMed ID: 19592390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jugular pit associated with 5q14.3 deletion incorporating the MEF2C locus: a recurrent clinical finding.
    Al-Shehhi M; Betts D; Mc Ardle L; Donoghue V; Reardon W
    Clin Dysmorphol; 2016 Jan; 25(1):23-6. PubMed ID: 26426104
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical characteristics in patients with interstitial deletions of chromosome region 12q21-q22 and identification of a critical region associated with keratosis pilaris.
    Al-Maawali A; Marshall CR; Scherer SW; Dupuis L; Mendoza-Londono R; Stavropoulos DJ
    Am J Med Genet A; 2014 Mar; 164A(3):796-800. PubMed ID: 24375972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.